DNA Test for Antidepressants Raises Questions From FDA

(Bloomberg) -- A company that helped pioneer genetic tests used to diagnose and treat disease lost more than 40% of its value on Wednesday, after U.S. regulators raised questions about whether a DN...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.